WPG Advisers’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.1K Buy
97
+1
+1% +$561 0.03% 304
2026
Q1
$53.9K Buy
96
+1
+1% +$641 0.04% 265
2025
Q4
$64.3K Buy
95
+3
+3% +$2.04K 0.05% 239
2025
Q3
$58.8K Sell
92
-5
-5% -$3.04K 0.05% 255
2025
Q2
$52K Buy
97
+10
+11% +$4.78K 0.04% 263
2025
Q1
$36.5K Sell
87
-8
-8% -$3.47K 0.03% 341
2024
Q4
$39.3K Buy
+95
New +$41.7K 0.04% 334

Other funds holding IDXX

WPG Advisers's IDXX Position: Q2 2026 in Review

WPG Advisers increased its Idexx Laboratories (IDXX) stake by 1% in Q2 2026, buying an estimated $561 and bringing the position to 97 shares worth $51.1K. The position accounts for 0.03% of the portfolio, ranked #304.

WPG Advisers first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $64.3K in Q4 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • WPG Advisers held 97 shares of Idexx Laboratories worth $51.1K as of Q2 2026.
  • WPG Advisers bought 1 Idexx Laboratories share in Q2 2026, an estimated $561.
  • Idexx Laboratories made up 0.03% of WPG Advisers's portfolio in Q2 2026, its #304 holding.
  • WPG Advisers first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Idexx Laboratories position peaked at $64.3K in Q4 2025.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.